• 0
    My Cart

    Click Here to Find How Many Items You Have Added:)

qq在线咨询
Home >> Peptides

Peptides(肽)

  1. Cat.No. 产品名称 Information
  2. GC66664 ((4-Chloro-3-(trifluoromethyl)phenyl)sulfonyl)valine ((4-Chloro-3-(trifluoromethyl)phenyl)sulfonyl)valine 是一种缬氨酸衍生物。
  3. GA24018 (2-(1,3-Dithiolan-2-yl)-Trp²?)-Liraglutide trifluoroacetate salt The peptide is an impurity of Liraglutide.
  4. GA24019 (2-(2-Trifluoromethyl-1,3-dithiolan-2-yl)-Trp²?)-Liraglutide trifluoroacetate salt The peptide is an impurity of Liraglutide.
  5. GA24020 (2-Hydroxy-Trp²?)-Liraglutide trifluoroacetate salt The peptide is an impurity of Liraglutide.
  6. GC68059 (2R,2'R)-4,4'-Disulfanediylbis(2-aminobutanoic acid) (2R,2'R)-4,4'-Disulfanediylbis(2-aminobutanoic acid) 是一种半胱氨酸衍生物。
  7. GC68248 (2R,3S)-3-Phenylisoserine hydrochloride

    Benzenepropanoic acid, β-amino-α-hydroxy-, hydrochloride, (αR,βS)-

     (2R,3S)-3-Phenylisoserine hydrochloride 是一种丝氨酸衍生物。
  8. GC66180 (2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3,4-difluorophenyl)propionic acid (2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3,4-difluorophenyl)propionic acid 是一种苯丙氨酸衍生物。
  9. GC68261 (2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3-fluorophenyl)propionic acid

    (S)-2-[(tert-Butoxycarbonyl)amino]-3-(3-fluorophenyl)propionic acid; tert-Butoxycarbonyl-L-3-fluorophenylalanine

     (2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3-fluorophenyl)propionic acid 是一种苯丙氨酸衍生物。
  10. GC68251 (2S)-4-(benzyloxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoic acid (2S)-4-(benzyloxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoic acid 是一种天冬氨酸衍生物。
  11. GC68224 (2S)-Methyl 2-(2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate (2S)-Methyl 2-(2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate 是一种缬氨酸衍生物。
  12. GC68083 (2S,3R)-Ethyl 2-amino-3-hydroxybutanoate hydrochloride (2S,3R)-Ethyl 2-amino-3-hydroxybutanoate hydrochloride 是一种苏氨酸衍生物。
  13. GC68238 (2S,4R)-1-((9H-Fluoren-9-yl)methyl) 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate (2S,4R)-1-((9H-Fluoren-9-yl)methyl) 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate 是一种脯氨酸衍生物。
  14. GC68225 (2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxylic acid (2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxylic acid 是一种脯氨酸衍生物。
  15. GC67811 (2S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid (2S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid 是一种脯氨酸衍生物。
  16. GC68105 (3-Aminopropyl)glycine (3-Aminopropyl)glycine 是一种甘氨酸衍生物。
  17. GC68128 (3R,4R)-4-(benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid (3R,4R)-4-(benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid 是一种苏氨酸衍生物。
  18. GC67959 (3S,4R,5S)-rel-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-neopentylpyrrolidine-2-carboxylic acid D-Proline, 3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-, (3S,4R,5S)-rel- 是一种脯氨酸衍生物。
  19. GC65232 (4R)-1-Boc-4-fluoro-D-proline

    N-BOC-顺式-4-氟-D-脯氨酸

     (4R)-1-Boc-4-fluoro-D-proline 是一种可用于制备拟肽、二氢吡啶和吡啶的氨基酸衍生物。
  20. GC66649 (4R)-2,2-Dimethyl-4-thiazolidinecarboxylic Acid (4R)-2,2-Dimethyl-4-thiazolidinecarboxylic Acid 是一种半胱氨酸衍生物。
  21. GC65484 (4S)-1-Boc-4-amino-D-proline

    (2R,4S)-4-氨基-1,2-吡咯烷二羧酸1-叔丁酯

     (4S)-1-Boc-4-amino-D-proline 是一种可用于合成化合物的氨基酸衍生物。
  22. GC65235 (4S)-1-Boc-4-fluoro-D-proline

    N-BOC-反式-4-氟-D-脯氨酸

     (4S)-1-Boc-4-fluoro-D-proline 是一种氟脯氨酸的衍生物，可用于化合物的合成。
  23. GC68190 (6S,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate (6S,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate 是一种苯丙氨酸衍生物。
  24. GA20024 (7-Diethylaminocoumarin-3-yl)carbonyl-Amyloid β-Protein (1-40) Amyloid β-protein (1-40) that is N-terminally modified with the fluorescent dye (7-diethylaminocoumarin-3-yl)carbonyl (DAC or DEAC). This derivative can be utilized to assess the binding properties of amyloid β-protein (1-40) for various membranes since it behaves very similar to the native peptide. In aqueous environments the fluorophore is almost non-fluorescent whereas binding to membranes results in an increase in fluorescence intensity (Λex = 430 nm, Λem = 470 nm). Increases in the GM1 ganglioside and cholesterol content in the lipid bilayers facilitated the binding of this peptide. For phosphatidylcholine and phosphatidylserine no affinity was observed.
  25. GA24022 (Ala¹³)-Apelin-13 (human, bovine, mouse, rat) (Salt form acetate)

    (Ala13)-Apelin 13, human

     (Ala13)-Apelin 13 showed scavenging abilities against active oxygen species such as superoxide and hydroxyl radicals.
  26. GA24023 (Ala¹³)-Apelin-13 (human, bovine, mouse, rat) (Salt form trifluoroacetate) Specific anatagonist of apelin-13.
  27. GA24021 (Ala¹)-PAR-4 (1-6) (mouse)

    (Ala¹)-Thrombin Receptor-Like 3 (1-6) (mouse)
  28. GC41696 (Ala1)-PAR4 (1-6) (mouse) (trifluoroacetate salt)

    H-Ala-Tyr-Pro-Gly-Lys-Phe-OH, AYPGKF

     A peptide agonist of PAR4
  29. GC41697 (Ala1)-PAR4 (1-6) amide (mouse) (trifluoroacetate salt)

    AY-NH2, AYPGKF-NH2, H-Ala-Tyr-Pro-Gly-Lys-Phe-NH2, PAR4-AP, Proteinase-Activated Receptor 4 Activating Peptide

     A peptide agonist of PAR4
  30. GA20029 (Arg¹³)-Amyloid β-Protein (1-40) H13R, a mutation in the metal-binding region of Abeta reduces its copper-mediated toxicity. The native rodent sequence containing an arginine at this position is more tolerant to metals than the human amyloid peptide.
  31. GC66389 (Arg)9 acetate

    Nona-L-arginine acetate; Peptide R9 acetate

     (Arg)9 (Nona-L-arginine) acetate 是一种由 9 个精氨酸残基组成的细胞穿透肽 (CPP)。(Arg)9 acetate 具有神经保护功能，在谷氨酸模型中 IC50 值为 0.78 μM。
  32. GC34977 (Arg)9 TFA

    Nona-L-arginine TFA; Peptide R9 TFA

     (Arg)9 TFA (Nona-L-arginine TFA)是可渗透细胞的多肽，在谷氨酸模型实验模型中保护神经的IC50值为0.78 μM。
  33. GC68684 (Arg)9, FAM-labeled (Arg)9, FAM-labeled 是一种带有 FAM 标记的 ARG，属于细胞穿透肽 (CPP)。CPPs 已成为一种强大的工具，用于将生物活性物质输送到完整细胞胞质中。
  34. GA20030 (Arg⁶)-Amyloid β-Protein (1-40) The English (H6R) mutation of β-amyloid peptides accelerates fibrillation without increasing protofibril formation. Ono et al. showed that the English and Tottori mutations alter Abeta assembly at its earliest stages, monomer folding and oligomerization, and produce oligomers that are more toxic to cultured neuronal cells than are wild type oligomers. The exchange of His? by Arg influences the structure of the Cu(II) complex formed by Aβ peptides.
  35. GA20038 (Asn²³)-Amyloid β-Protein (1-40) The Iowa (D23N) mutant of Aβ 40 considerably more rapidly assembles in solution to form fibrils than the WT Aβ sequence. These fibrils also show a different structure, which could be responsible for their increased toxicity.
  36. GA20039 (Asn⁶⁷⁰,Leu⁶⁷¹)-Amyloid β/A4 Protein Precursor₇₇₀ (667-675) SEVNLDAEF corresponds to the mutant junctional sequence of the amyloid precursor protein (APP) found in a Swedish family with early-onset Alzheimer's disease, therefore referred to as the 'Swedish' mutation (K670N/M671L). The peptide has been used for assaying cleavage at leucine-aspartate by cathepsin G and chymotrypsin, whereas neither cathepsin B, D nor L generated any products.
  37. GA20040 (Asn⁶⁷⁰,Leu⁶⁷¹)-Amyloid β/A4 Protein Precursor₇₇₀ (667-676)

    Β-基质分泌酶Ⅱ

     This peptide substrate corresponds to the 'Swedish' Lys-Met/Asn-Leu (K670N/M671L) mutation of the amyloid precursor protein (APP) β-secretase cleavage site. It has been used for assaying β-secretase activity.
  38. GA20041 (Asn⁶⁷⁰,Sta⁶⁷¹,Val⁶⁷²)-Amyloid β/A4 Protein Precursor₇₇₀ (662-675) Amyloid precursor protein (APP) β-secretase from human brain cleaves full-length APP at the amino terminus of the amyloid β-protein (Aβ) sequence, thus leading to the generation and extracellular release of β-cleaved soluble APP and a corresponding cell-associated carboxy-terminal fragment. The subsequent cleavage of the C-terminal fragment by γ-secretase(s) leads to the formation of Aβ. This new peptide represents a potent substrate analog inhibitor of APP β-secretase with IC?? = 30 nM.
  39. GA20042 (Asn⁷)-Amyloid β-Protein (1-40) The Tottori (D7N) mutation of β-amyloid peptides accelerates fibrillation without increasing protofibril formation. Ono et al. showed that the English and Tottori mutations alter Abeta assembly at its earliest stages, monomer folding and oligomerization, and produce oligomers that are more toxic to cultured neuronal cells than are wild type oligomers.
  40. GA20045 (Asp³⁷)-Amyloid β-Protein (1-42) The G37D mutant does not show the aggregation behavior of WT Abeta42 nor its neurotoxicity.
  41. GA24025 (Aspartimide²¹)-Glucagon trifluoroacetate salt The peptide is an impurity of glucagon.
  42. GA24024 (Aspartimide¹?)-Glucagon trifluoroacetate salt The peptide is an impurity of glucagon.
  43. GC68109 (Cyclohexanecarbonyl)-L-leucine (Cyclohexanecarbonyl)-L-leucine 是一种亮氨酸衍生物。
  44. GA24026 (Cys(S)²)-Octreotide Potential impurity of octreotide.
  45. GA20050 (Cys⁰)-Amyloid β-Protein (1-40) Cys-Aβ1-40 can be easily and selectively modified, labeled, coupled to carriers e.g. by maleimide chemistry without affecting the sequences involved in fibril formation. The free mercapto moiety of the peptide adheres to gold surfaces.
  46. GA20053 (Cys²⁶)-Amyloid β-Protein (1-40) Aβ40 S26C has been used for generating the covalently linked Aβ40 homodimer. Dimerization can be easily reverted by reducing the soluble dimer with thiols as β-mercaptoethanol. Aβ40 S26C is perfectly suited for labeling with fluorescent tags
  47. GA20052 (Cys²⁶)-Amyloid β-Protein (1-40) (Dimer) Dimer of H-7402.
  48. GA20054 (Cys⁴⁷)-HIV-1 tat Protein (47-57) (Cys⁴⁷)-HIV-1 tat 蛋白 (47-57) 具有膜易位功能，可用于衍生磁性药物的表面并大大促进其被靶细胞吸收。
  49. GA24027 (Cysteinol?,des-L-threoninol?)-Octreotide Impuritiy of octreotide.
  50. GA24028 (d(CH?)?¹,D-Ile²,Ile?,Arg?,Tyr?)-Vasopressin

    d(CH2)5[D-Ile2,Ile4,Tyr9]-AVP

     AVP antagonist specifically targeting the rat V2 receptor.
  51. GA24029 (d(CH?)?¹,Tyr(Me)²,Dab?,Arg?)-Vasopressin

    d(CH2)5[Tyr(Me)2,Dab5]-AVP

     The isosteric substitution of Asn5 by Dab in oxytocin, vasopressin and their analogs invariably leads to a dramatic loss of the biolical activities of the peptides.

Items 101 to 150 of 2505 total

per page
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5

Set Descending Direction